Infergen



Combined with:

Indications and Reactions:

Role Indications Reactions
Primary
Hepatitis C 83.4%
Product Used For Unknown Indication 5.0%
Multiple Myeloma 4.1%
Drug Use For Unknown Indication 3.3%
Hepatitis C Virus 1.2%
Hepatitis C Virus Test 0.8%
Depression 0.6%
Hypertension 0.4%
Diabetes Mellitus 0.2%
Hepatitis 0.2%
Neutropenia 0.2%
Schizophrenia 0.2%
Type 2 Diabetes Mellitus 0.2%
White Blood Cell Count Decreased 29.2%
Weight Decreased 16.7%
Vomiting 6.7%
Nausea 5.0%
Wrong Technique In Drug Usage Process 5.0%
Haemoglobin Decreased 3.3%
Tremor 3.3%
Fatigue 2.5%
Neutropenia 2.5%
Pneumonia 2.5%
Pulmonary Embolism 2.5%
Pyrexia 2.5%
Self-medication 2.5%
Sluggishness 2.5%
Thrombocytopenia 2.5%
Transient Ischaemic Attack 2.5%
Vision Blurred 2.5%
Visual Impairment 2.5%
Autoantibody Positive 1.7%
Blood Glucose Increased 1.7%
Secondary
Hepatitis C 91.5%
Drug Use For Unknown Indication 2.8%
Anaemia 1.0%
Anaemia Of Chronic Disease 0.8%
Hepatitis C Virus 0.8%
Product Used For Unknown Indication 0.8%
Haemoglobin Decreased 0.5%
Hepatitis 0.5%
Hepatitis C Virus Test 0.5%
Chronic Hepatitis 0.3%
Irritability 0.3%
Trigeminal Neuralgia 0.3%
White Blood Cell Count Decreased 23.5%
Platelet Count Decreased 6.2%
Syncope 6.2%
Weight Decreased 6.2%
Electrolyte Imbalance 4.9%
Presyncope 4.9%
Transient Ischaemic Attack 4.9%
Vomiting 4.9%
Drug Ineffective 3.7%
Nephrolithiasis 3.7%
Pneumonia 3.7%
Pyrexia 3.7%
Serum Ferritin Increased 3.7%
Swollen Tongue 3.7%
Thrombocytopenia 3.7%
Anaemia 2.5%
Colitis 2.5%
Delusion 2.5%
Dyspnoea 2.5%
Pulmonary Embolism 2.5%
Concomitant
Hepatitis C 64.5%
Pre-existing Disease 9.7%
Hepatic Encephalopathy 6.5%
Anaemia 3.2%
Depression 3.2%
Hepatitis B 3.2%
Insomnia 3.2%
Liver Disorder 3.2%
Neutropenia 3.2%
Fatigue 15.0%
Rash 15.0%
White Blood Cell Count Decreased 10.0%
Anaemia 5.0%
Cerebrovascular Accident 5.0%
Drug Intolerance 5.0%
Encephalopathy 5.0%
Nausea 5.0%
Pallor 5.0%
Pruritus 5.0%
Pyrexia 5.0%
Swelling Face 5.0%
Therapy Non-responder 5.0%
Visual Disturbance 5.0%
Weight Decreased 5.0%